Literature DB >> 32371081

Effects of Different Orientations of Cage Implantation on Lumbar Interbody Fusion.

Yan Liang1, Yongfei Zhao2, Shuai Xu1, Zhenqi Zhu1, Haiying Liu1, Keya Mao3.   

Abstract

BACKGROUND: Transforaminal lumbar interbody fusion (TLIF) via a fusion cage is widely carried out to treat degenerative lumbar spinal disease, and cage implantation plays a pivotal role in buttressing the vertebrae and promoting fusion. Clinically, the cage implantation is commonly placed in 2 different orientations: oblique and traverse. Therefore, this study aimed to explore the effects of different orientations of cage implantation on lumbar interbody fusion.
METHODS: From January 2016 to January 2018, a retrospective study of 98 patients with lumbar degenerative disease who were treated with lumbar interbody fusion with at least 2-year follow-up was performed. According to the different positions of cage implantation, the patients were divided into 2 groups: oblique group (OG) and traverse group (TG). The clinical and radiographic outcomes were compared preoperatively, postoperatively, and at last follow-up evaluation. Radiographic measurements included the height of intervertebral (HOI) disk, segment lordosis (SL), lumbar lordosis (LL), the distance between the posterior of cage and vertebrae postoperatively (D1), the distance at final follow-up (D2), and the distance of cage move (D3). Radiographic evaluation of fusion integrity was performed based on the Bridwell interbody fusion grading system at the final follow-up.
RESULTS: There was no significant difference between the 2 groups in terms of sex, age, surgical levels, operative time, intraoperative blood loss, time to ambulation, and length of hospital stay (P > 0.05). The HOI disk, SL, and LL in the 2 groups were noticeably improved postoperatively compared with preoperatively (P > 0.05), and there was no significant difference between the 2 groups (P > 0.05). However, at the final follow-up, HOI disk, SL, and LL in the TG were larger than those in the OG (P < 0.05). D1 and D2 in the TG were larger than those in the OG, and there was a significant difference between the 2 groups (P < 0.05). D3 in the OG was larger than that in the TG (P < 0.05). All patients achieved grade I fusion at the final evaluation.
CONCLUSIONS: The traverse cage implantation in TLIF had the same clinical effect as oblique cage implantation, but is superior in improving sagittal alignment. Therefore, we advise that the cage should be placed in traverse orientation in TLIF.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cage implantation; Height of intervertebral; Lumbar interbody fusion; Lumbar lordosis; Segment lordosis

Mesh:

Year:  2020        PMID: 32371081     DOI: 10.1016/j.wneu.2020.04.167

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  4 in total

1.  Finite Element Analysis of a Novel Fusion Strategy in Minimally Invasive Transforaminal Lumbar Interbody Fusion.

Authors:  Zhenchuan Han; Bowen Ren; Long Zhang; Chao Ma; Jianheng Liu; Jiantao Li; Xiao Liu; Qingzu Liu; Keya Mao; Peifu Tang
Journal:  Biomed Res Int       Date:  2022-05-11       Impact factor: 3.246

2.  Prevalence and risk factors for cage subsidence after lumbar interbody fusion: A protocol for systematic review and meta-analysis.

Authors:  Qiujiang Li; Xingxia Long; Lin Shi; Yinbin Wang; Tao Guan; Jinhan Lv; Lijun Cai
Journal:  Medicine (Baltimore)       Date:  2021-12-10       Impact factor: 1.817

3.  Do Radiographic Results of Transforaminal Lumbar Interbody Fusion Vary with Cage Position in Patients with Degenerative Lumbar Diseases?

Authors:  Qing Ding; Xiangyu Tang; Ruizhuo Zhang; Hua Wu; Chaoxu Liu
Journal:  Orthop Surg       Date:  2022-03-18       Impact factor: 2.071

4.  Impact of cage position on biomechanical performance of stand-alone lateral lumbar interbody fusion: a finite element analysis.

Authors:  Chong Nan; Zhanbei Ma; Yuxiu Liu; Liang Ma; Jiaqi Li; Wei Zhang
Journal:  BMC Musculoskelet Disord       Date:  2022-10-18       Impact factor: 2.562

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.